Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2

Conditions

Neoplasms 6Venous Thrombosis 5Venous Thromboembolism 2Pulmonary Embolism 2Thrombosis 1Thromboembolism 1Hemostatic Disorders 1

Interventions

Dalteparin 10apixaban 9Tinzaparin 4Enoxaparin 4Heparin, Low-Molecular-Weight 3edoxaban 2abelacimab 2Rivaroxaban 2MAA868 2Dabigatran 2perflutren 1isoquercitrin 1enoxaparin sodium 1bemiparin 1Warfarin 1Sulfur Hexafluoride 1Rosuvastatin Calcium 1Hospitals 1Fondaparinux 1Fluorodeoxyglucose F18 1Educational Status 1Deoxyribonucleases 1Acetylcysteine 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Pulmonary Embolism × edoxaban × Clear all
NCT02744092 2023-10-03

CANVAS

Alliance Foundation Trials, LLC.

Phase NA Completed
811 enrolled 19 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡